BioNTech SE ROI - Return on Investment 2019-2024 | BNTX

BioNTech SE return on investment for the quarter ending June 30, 2024 was -2.48.

  • BioNTech SE average return on investment for 2023 was 17.35, a 78.72% decline from 2022.
  • BioNTech SE average return on investment for 2022 was 81.52, a 42.82% decline from 2021.
  • BioNTech SE average return on investment for 2021 was 142.56, a 7564.52% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

BioNTech SE ROI - Return on Investment 2019-2024 | BNTX

  • BioNTech SE average return on investment for 2023 was 17.35, a 78.72% decline from 2022.
  • BioNTech SE average return on investment for 2022 was 81.52, a 42.82% decline from 2021.
  • BioNTech SE average return on investment for 2021 was 142.56, a 7564.52% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.